• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryCOVID-19 vaccines

To raise COVID vaccination rates, rely on primary care physicians

By
Stanley M. Bergman
Stanley M. Bergman
Down Arrow Button Icon
By
Stanley M. Bergman
Stanley M. Bergman
Down Arrow Button Icon
May 7, 2021, 11:30 AM ET
America has “hit the wall of vaccine hesitancy,” writes Stanley M. Bergman. “And the only way to clear the wall is to engage those health care professionals most able to persuade the hesitant to take a shot.”
America has “hit the wall of vaccine hesitancy,” writes Stanley M. Bergman. “And the only way to clear the wall is to engage those health care professionals most able to persuade the hesitant to take a shot.”Sarah Reingewirtz—Los Angeles Daily News/SCNG/Getty Images

It’s critical that we get the COVID-19 vaccine. It’s also critical where we can get the vaccine.

The Biden administration acknowledged this fact on May 4 when it announced plans to “launch a comprehensive strategy to make vaccinations available in more places—with a focus on pediatricians and family physicians—and to continue to build trust with teens and their parents.” 

Who better to build trust than a family’s primary care doctor? How better to distribute the vaccine than through the well-established, highly efficient private sector health care distribution channel that regularly distributes much of the nation’s vaccines?  

Henry Schein has been promoting for months the benefit of engaging these physicians in the vaccine rollout, because we understood that at some point, we’d hit the wall of vaccine hesitancy. We are there now, and the only way to clear the wall is to engage those health care professionals most able to persuade the hesitant to take a shot.  

But there’s a wrinkle.

At this juncture, the Biden administration’s plan to engage physicians continues to rely on distribution primarily through states, which has been challenging—both for the states and for physicians. State and local authorities tell us it has been difficult to distribute the vaccine and the related kits to smaller sites, such as physicians’ offices, because government logistics networks do not traditionally serve what are essentially small businesses accustomed to working through established distribution channels. While this is a complex process for the states, it is what private sector health care products distributors do easily every day. 

A significant number of Americans already receive flu and other vaccines from office-based physicians because a well-established, effective and efficient private sector supply chain exists. We just need to tap into this existing supply chain for COVID vaccines, as appropriate, given various cold-chain storage requirements. We also recognize that the nation will swiftly need to prepare for the delivery of booster COVID vaccines which, like flu vaccines, may require annual administration. Again, the private sector supply chain, of which my company is a part, is built for this purpose.

To be sure, thus far, the nation’s COVID-19 vaccination effort has been nothing short of extraordinary in quickly getting shots in arms. But we also recognize that the country is now in a race against the variants, that we continue to see equity challenges in the uptake of the vaccine, and that there are high rates of vaccine hesitancy in some areas. 

As we enter this new phase in the vaccination campaign, where the scale has tipped so that supply outweighs demand, we must more effectively engage office-based practitioners to get us to the government’s goal of another 100 million doses delivered in 60 days. In fact, the highly regarded Harris Poll released data earlier this year showing that Americans, by far, trust the opinion of “my doctor” regarding the vaccine more than any other source’s opinion and are most comfortable receiving the vaccine at “my doctor’s office.”  

Family physicians have a physical presence in every community nationwide—large and small, rural and urban—which provides an advantage in addressing the dual challenge of vaccine hesitancy and health inequity. But according to a survey by the Primary Care Collaborative, only about 38% of the hundreds of thousands of primary care physicians in the country are offering COVID vaccines, in part because of the challenges they face under the state-by-state approach.

If we’re serious about a full-scale vaccine rollout, which requires overcoming distrust, we need to place office-based physicians front and center in the fight. These physicians know their patients, and patients trust what they learn from their own doctors, who can explain in detail how the vaccines work, why they are safe, and why getting everyone vaccinated as soon as possible is vital to achieving herd immunity and restoring public health.

This vast network of physicians and dentists in the U.S. can be immediately activated literally overnight. This is why we have been advocating with the administration and Congress to highlight the need for a broader role for office-based physicians and to deploy the highly efficient supply chain that exists for exactly this reason. 

To get the unwilling to accept the vaccine, we must first accept the reality that highly trusted family physicians are essential to the rollout, and to accelerating our return to normalcy.

Stanley M. Bergman is chairman of the board and CEO of Henry Schein Inc.

More opinion from Fortune:

  • Why the new, bolder U.S. climate goal will boost the economy
  • Designing for trust: Business lessons from an underdog ride-share startup
  • 5 things Western investors misunderstand about China
  • Tech entrepreneurs grab the headlines, but COVID relief should target grass-roots small businesses
  • Elon Musk might be hosting SNL, but Tesla workers aren’t laughing
Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.
About the Author
By Stanley M. Bergman
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

valerie
CommentaryLayoffs
Tesla’s former HR chief: the AI layoff panic Is built on a false premise—here’s what most workers need to know
By Valerie Capers WorkmanMay 1, 2026
42 minutes ago
tamas
CommentaryPolymarket
SEON CEO: Prediction markets can forecast the future. Can they survive their own manipulation problem?
By Tamas KadarMay 1, 2026
4 hours ago
sundar
Commentary250 Years of Innovation
America at 250: immigration and the making of an innovative nation
By Nasser KazeminyMay 1, 2026
5 hours ago
Derek Kilmer
CommentaryEconomics
The U.S. economy is booming — just not where 50 million Americans live
By Derek KilmerMay 1, 2026
5 hours ago
hegseth
CommentaryMilitary
America shot its arsenal empty in 2 wars. Now it needs Beijing’s permission to reload
By Steve H. Hanke and Jeffrey WengApril 30, 2026
20 hours ago
Duncan Tait, CEO of Inchcape
Europecar manufacturing
“Competition is good for the industry”. Inchcape CEO’s case for optimism in automotive’s next chapter
By Duncan TaitApril 30, 2026
23 hours ago

Most Popular

China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
North America
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
By Jake AngeloApril 30, 2026
20 hours ago
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
By Preston ForeApril 27, 2026
4 days ago
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
Conferences
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
By Nick LichtenbergApril 29, 2026
2 days ago
America shot its arsenal empty in 2 wars. Now it needs Beijing's permission to reload
Commentary
America shot its arsenal empty in 2 wars. Now it needs Beijing's permission to reload
By Steve H. Hanke and Jeffrey WengApril 30, 2026
20 hours ago
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
By Alexei OreskovicApril 29, 2026
2 days ago
Exclusive: America's largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth
Banking
Exclusive: America's largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth
By Nick LichtenbergApril 29, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.